Abstract
tablished by a differential sensitivity of single-cells to TRAIL. An intuitive result considering that the sensitivity of a signaling pathway to its cognate ligand is tuned by the abundances of its com-113 ponents. In apoptosis for example, we would expect that the number of TRAIL receptors on a 114 cell's surface, the number of pro-caspase molecules, the number of Bax molecules, the number of 115 mitochondria, etc contribute to that cell's response to a single dose of TRAIL. If each one of these 116 molecules varied from one cell to the next, the so-called cell-to-cell variability (CCV), we should 117 expect that the individual response of cells to TRAIL are unique.
118
Indeed, the probability density of ρ shows that the endogenous density of mitochondria vary 119 from cell-to-cell (Figures 1E, H) . If each cell's sensitivity to TRAIL were anti-correlated with mi-120 tochondria abundance we would expect an enrichment of high mitochondria density cells with 121 TRAIL stimulation. Such an effect can be quantitatively studied by using the rule of probability.
122
By applying Bayes' theorem we may associate the changes in the probability density ρ with the 123 quantitative change of the fraction of living cells. From this simple property of probability, we 124 were able to develop a quantitative strategy to gauge whether the observed endogenous variability 125 of biological components are responsible for functional population diversity.
126
Variability in all-or-none biological responses 127 As found in other biological systems, e.g. MAPK and NFκB [26, 27] , the conversion of a con-128 tinuous input to a binary response limits the influence of CCV in cellular components to CCV in 129 sensitivity to perturbations. In apoptosis, each cell, with its unique concentrations of molecular 130 components, should require a specific concentration of TRAIL to induce cell death. At the popu-131 lation level the diversity in single-cell sensitivities to TRAIL gives rise to the fractional control of 132 cell death.
133
As an example, consider two separate ensembles of cells, one with near identical biomolecu-134 lar composition (low CCV) and the other with variable numbers of its components (high CCV).
135
In the scenario where all components are near equal, the individuals will undergo the life-death 136 transition at nearly the same dose of ligand ( Figure 2A ). In contrast, when CCV is relatively high, 137 the individual cells of the ensemble will transition from live to dead at diverse doses of TRAIL (Figure 2B Lets assume that the sensitivity of cells to TRAIL is wholly dependent on the biological compo-158 nents of the apoptotic signaling pathway. For simplicity lets designate the mitochondria density 159 ρ to be x 0 and all other contributing components as x 1 , x 2 , . . . , x m . A priori any mathematical 160 function that describes the intricate relationships of these components and the dose of TRAIL to 161 the single cell sensitivity (κ) is unknown, however we may expand this a priori unknown function 162 to an arbitrary order by,
where log(IC 50 (ρ)) = log(IC 50 ) + k ρ δ log(ρ).
Then, in like fashion, the resulting Hill coefficient comes from estimating the variance of sensitiv-175 ities conditioned on mitochondria density, 
Eq. 4 gives us a detailed understanding on the influence of mitochondria density, or in general 
186
To see this in detail, lets consider an example of an arbitrary pathway consisting of three com-187 ponents that takes s as input and provides a binary output y ( Figure 3A) . We then make a synthetic 188 data set representing virtual single cell flow cytometry measurements for different doses of s (Fig-189 ure 3B). Using these data, we can compute the populations response to the stimulation, and due to with a binary label y = 1. The filled regions of the curves in P (y = 1|u, s) for u = x, z, or q ( ure 3C) represent the model predictions from inferred k u ± 3 standard deviations. These inferred 207 parameters were then used to infer the single cell dose functions ( Figure 3D ) with qualitatively 208 excellent agreement. Quantitatively, we see that we can infer the conditional Hill coefficients ure 3E), the corresponding variances explained ( Figure 3F ), and lastly the dependence of the single 210 cell sensitivities on each biological component ( Figure 3G ).
211
Mitochondria density is a source of cell-to-cell variability
212
We apply our new statistical framework, DEPICTIVE, to quantitatively dissect the dependence 
224
Bax concentration dependence on mitochondria surface area
225
To gain mechanistic insight in the functional role of mitochondria density in the cell death decision,
226
we developed a coarse-grained dynamic model of apoptosis ( Figure 5A abundance of the lower fixed point ( Figure 5F ). In doing so, cells with mitochondria density in the 261 bistable region equally increase their susceptibility to cell death from fluctuations in IC abundance.
262
The Jurkat model's response to TRAIL exhibits an increase of the density of mitochondria that sep-
263
arates the monostable high and bistable IC abundance regions ( Figure 5G ). Therefore, an individual 264 cell's mitochondria density determines its sensitivity to TRAIL induced cell death. Together, these 265 model-based observations propose an explanation for how CCV in mitochondria density influences 266 the response of Jurkat but to a lesser extent MDA-MB-231 cells to TRAIL (Figures 5H,I ).
267
Sensitizing MDA-MB-231 cells to CCV in mitochondria density Bcl-2 inhibition, we found that the sensitivity of the fractional response of the cell population to
273
TRAIL increases ( Figure 6B ). Furthermore, and as intuited, Bcl-2 inhibition increased the depen-
274
dence of single-cell sensitivities to TRAIL on mitochondria density ( Figure 6D ). We corroborated goodness-of-fit analysis). Remarkably, Bcl-2 inhibition alone increased the variance of sensitivi-278 ties attributable to mitochondria density from 0% to 40% ( Figure 6F ).
279

Discussion
280
We have unveiled a connection in the cell-to-cell variability of mitochondria density to the frac- . The inset shows that the Pearson correlation marginally changes for each TRAIL dose. The probability density of mitochondria density (ρ) for each dose of TRAIL that elicits a unique response in MDA-MB-231 cells (H). In (E) and (H) the single cell measurements from each of the lowest three doses of TRAIL are aggregated prior to probability density estimation (Violet). Visual inspection of the respective dose response curves suggest that these three doses of TRAIL are effectively identical. Data presented with errorbars represent the mean ± one standard error of the mean over triplicate experiments. . We may make the dependence of cell survival to TRAIL by examining the probability of the cell state, y = 1, given the dose and abundance of each biological component (right column). In the right column, the circles represent the true conditional probability, while the blue line and shaded region represents the DEPICTIVE inferred dependence ± three standard deviations. (D) If we eliminate each individual source of CCV, the dose response is less uncertain. A phenomena that is well parameterized by the Hill coefficient (E), and the corresponding variance explained (F). Error bars represent ± one standard deviation. (G) The scaling of the IC 50 (u) with u. Figure 4E for [0, 1, 3, 10] µM doses of the Bcl-2 Inhibitor ABT-263. (F) The fraction of variance in single-cell sensitivities (σ) explained by mitochondria density CCV in E (σ ρ ). Note that all simulations were conducted with 100 cells for each of the 20 doses of TRAIL, 12 densities of mitochondria, and 9 doses of inhibitor. Detailed analysis of each replicate data set are presented in Supplementary Figures 6-8. 
